Guggenheim Starts Ligand Pharma (LGND) at Neutral
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $70.37 -0.89%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Guggenheim analyst Dana Flanders initiates coverage on Ligand Pharma (NASDAQ: LGND) with a Neutral rating.
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $107.55 yesterday.
You May Also Be Interested In
- Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
- JPMorgan Starts Accent Group Ltd. (AX1:AU) at Overweight
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
